Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia [Phase 2]
A Phase 2 study evaluating Solbinsiran (LY3561774) in participants with severe hypertriglyceridemia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition [NA]
This clinical trial is investigating whether foods rich in omega-3 polyunsaturated fatty acids affect triglyceride levels and lipoprotein co…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: WB-EMS Effects on Cardiometabolic Risk Factors [NA]
A university-sponsored clinical trial is evaluating the effects of WB-EMS on cardiometabolic risk factors in adults with hypertension and me…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia [Phase 3]
A Phase 3 clinical trial is evaluating the long-term safety and efficacy of Plozasiran in adults with hypertriglyceridemia, with recruitment…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Russian Extreme Hypertriglyceridemia Registry
This entry notes that the Russian Extreme Hypertriglyceridemia Registry is actively recruiting participants to study severe hypertriglycerid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias [Phase 1]
The trial is a Phase 1 safety and tolerability study of CTX310 in participants with refractory dyslipidemias. It is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Single-ascending Dose Study of Kylo-12 in Healthy Subjects [Phase 1]
Phase 1 single-ascending-dose study of Kylo-12 in healthy subjects to assess safety and pharmacokinetics for hypertriglyceridemia; the trial…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis [Phase 2]
A Phase II clinical trial is evaluating the efficacy and safety of HRS-7249 and SHR-1918 in adults with severe hypertriglyceridemia at high …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque [NA]
Clinical trial evaluating the efficacy and safety of DR10624 in patients with hypertriglyceridemia and carotid atherosclerosis is currently …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food [NA]
A pilot clinical trial investigating Bottarga supplementation is currently recruiting to evaluate effects on metabolic conditions.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: A Study of SHR-1918 In Participants With Hypertriglyceridemia [Phase 3]
A Phase 3 study evaluating SHR-1918 for hypertriglyceridemia is planned. The trial is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis [Phase 3]
A Phase 3 clinical trial of Plozasiran in adults with severe hypertriglyceridemia at risk of acute pancreatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia [Phase 2]
A Phase 2 trial evaluating MN-001 in patients with non-alcoholic fatty liver disease and comorbid type 2 diabetes mellitus and hypertriglyce…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insulin Resistance Phenotypes [NA]
This clinical trial investigates how hepatic triglyceride biosynthesis varies across insulin resistance phenotypes in people with hypertrigl…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol [Phase 2]
Phase 2 clinical trial evaluating MAR001 in adults with hypertriglyceridemia (including remnant cholesterol); the study is currently active …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia [Phase 1, Phase 2]
A Phase 1b/2a study of JMT202 injection for hypertriglyceridemia is currently recruiting, sponsored by Shanghai JMT-Bio Inc.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) [Phase 3]
Phase 3 trial update for Olezarsen (ISIS 678354) in severe hypertriglyceridemia; the CORE-OLE study is currently active but not recruiting p…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia [Phase 1]
A Phase 1b clinical trial evaluating VERVE-201 for patients with refractory hyperlipidemia is currently recruiting to assess safety and phar…
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol [Phase 2]
A Phase 2 mechanistic study investigating MAR001 in adults with elevated triglycerides and remnant cholesterol is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia [Phase 3]
This entry updates the status of a Phase 3 trial evaluating Plozasiran (ARO-APOC3) in adults with severe hypertriglyceridemia, noting the st…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Study of Plozasiran in Adults With Severe Hypertriglyceridemia [Phase 3]
Phase 3 trial status update for Plozasiran in adults with severe hypertriglyceridemia, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia [Phase 3]
Phase 3 trial update indicating the study of Plozasiran in adults with hypertriglyceridemia is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Differential Thrombogenesis by EPA and DHA Mediated by HDL [EARLY_Phase 1]
Early-phase trial evaluating differential thrombogenesis by EPA versus DHA mediated by HDL in lipid metabolism disorders, currently recruiti…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma
A clinical trial investigating whether high-speed centrifugation improves measurement of anti-Xa activity in lipemic plasma from individuals…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation [NA]
A clinical trial is evaluating whether curcumin and astaxanthin can lower triglyceride levels and inflammatory markers; the study is current…